the Board of Directors of our company at their Board Meeting held on Friday the 14th day of November, 2025 started at 01.00 P.M. and concluded at 02.00 P.M. at the registered office of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Flora Corporation's board, meeting on 14 Nov 2025, approved unaudited standalone results for Q2 and H1 FY26. Revenue from operations stood at Rs. 1,632.88 lakhs for Q2 FY26 vs Rs. 1,359.70 lakhs in Q2 FY25, a YoY growth of about 20%. However, H1 FY26 revenue fell sharply to Rs. 2,956.12 lakhs from Rs. 5,089.13 lakhs in H1 FY25, a decline of roughly 42%. The company continued to post losses, though narrower: H1 FY26 loss before tax was Rs. 83.55 lakhs vs Rs. 149.32 lakhs a year ago, with EPS at Rs. (0.96). Reserves remained negative at Rs. (474.85) lakhs and total equity slipped to Rs. 398.54 lakhs. Auditor M/s Sapna Toshniwal & Co. issued a clean (unmodified) limited review report. The company also confirmed non-applicability of related-party transaction disclosure norms.
Short-term: positive Q2 revenue growth and reduced losses are mildly encouraging, but the sharp H1 revenue fall, persistent losses, and negative reserves signal ongoing financial stress, which could weigh on the stock and investor sentiment.